Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
48 studies found for:    Open Studies | "Niacin"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
Conditions: Chronic Renal Failure;   Hemodialysis
Interventions: Drug: nicotinamide;   Drug: sevelamer;   Drug: cinacalcet
2 Recruiting Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
Conditions: Coronary Artery Disease;   Carotid Artery Diseases;   Atherosclerosis
Interventions: Drug: Atorvastatin;   Drug: Niacin;   Drug: Colesevelam;   Drug: Placebo Niacin;   Drug: Placebo Colesevelam
3 Recruiting Effects of Niacin Therapy on Lipoprotein Composition and Function
Condition: Cardiovascular Disease
Intervention: Dietary Supplement: Niacin Extended Release
4 Recruiting Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention: Dietary Supplement: Niacinamide
5 Recruiting Nicotinamide Safety Study
Conditions: Pregnancy Induced Hypertension;   Superimposed Preeclampsia;   Hypertension
Intervention: Drug: Nicotinamide
6 Unknown † Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
Condition: Dyslipidemia
Interventions: Drug: High-dose rosuvastatin;   Drug: Statin plus fenofibrate;   Drug: Statin plus niacin ER/laropiprant
7 Not yet recruiting The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
Condition: Chronic Kidney Disease
Interventions: Drug: Nicotinamide;   Drug: Lanthanum Carbonate;   Drug: Placebo (for Nicotinamide);   Drug: Placebo (for lanthanum carbonate)
8 Unknown † The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker
Condition: Hypercholesterolemia
Intervention: Drug: Niacin\Laropiprant
9 Unknown † Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)
Condition: Coronary Artery Disease
Interventions: Drug: Niacin;   Drug: Niacin+Statin
10 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo
11 Recruiting Skin Maturation in Premature Infants
Condition: Premature Birth of Newborn
Intervention: Other: Vitamin B3 (Nicotinamide)
12 Recruiting Effects of Niacin On Fatty Acid Trapping
Condition: Dyslipidemia
Interventions: Dietary Supplement: Oral Fat Challenge;   Other: Indocyanine Green;   Dietary Supplement: Nialor;   Dietary Supplement: Niaspan
13 Recruiting Effect of Nicotinamide in Friedreich's Ataxia
Condition: Neurodegenerative Disorders
Intervention: Drug: nicotinamide
14 Unknown † Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression
Condition: Healthy
Intervention: Drug: nicotinic acid
15 Not yet recruiting The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men
Condition: Obese
Interventions: Dietary Supplement: Nicotinamide riboside (NIAGEN TM, ChromaDex, CA, USA );   Dietary Supplement: Placebo
16 Unknown † Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)
Conditions: Dyslipidemia;   Atherosclerosis
Interventions: Drug: simvastatin;   Drug: Nicotinic Acid
17 Recruiting A Study to Evaluate the Use of the Drug Combination Vorinostat, Niacinamide, and Etoposide in Patients With Lymphoid Malignancies That Have Reoccurred
Conditions: Hodgkin's Disease;   Non-Hodgkin's Lymphoma
Interventions: Drug: Vorinostat (SAHA) and Niacinamide;   Drug: Vorinostat, Niacinamide and Etoposide
18 Not yet recruiting Early Aortic Valve Lipoprotein(a) Lowering Trial
Condition: Aortic Stenosis and Lipoprotein(a) Levels
Interventions: Drug: Extended release Niacin;   Drug: Placebo Comparator
19 Unknown † Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL
Condition: Metabolic Syndrome
Intervention: Drug: Pioglitazone +/- placebo in combination with niacin ER
20 Unknown † Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis
Condition: Psychosis
Intervention: Drug: Niaspan
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years